Tradestie Institutional Equity Comparison Engine

RADX vs ABP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABP Overall Edge

ABP Captures Institutional Edge (1โ€“1 Pillars ยท 3โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abpro Holdings, Inc Common Stock (ABP) driven by superior Growth & Margin while RADX counters with relative strength in Momentum & Technical. Fundamentally, RADX trades at N/M Forward P/E with -411.6% operating margin (-36.9% YoY revenue) versus ABP at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, RADX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RADX N/M vs ABP N/M Fwd P/E
Growth & Margin Winner ABP
Op Margin -411.6% vs 0.0% ยท YoY -36.9% vs -100.0%
Momentum & Technical Winner RADX
1Y -86.0% vs -98.2% ยท 52W Pos 0% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RADX NASDAQ
Radiopharm Theranostics Limited American Depositary Shares
Pharmaceutical Preparations
$0.63
-6.33% 1D
Market Cap $10.6M
1M Return -33.64%
1Y Return -86.04%
Forward P/E N/M
Unified AI Score
41.1 / 100 SELL
Tech 25.0 Fund 45.0 Flow 50.0 Mom 55.0
ABP NASDAQ
Abpro Holdings, Inc Common Stock
Biological Products, (No Disgnostic Substances)
$0.52
-34.76% 1D
Market Cap $2.2M
1M Return -84.04%
1Y Return -98.23%
Forward P/E N/M
Unified AI Score
44.4 / 100 HOLD
Tech 40.0 Fund 49.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RADX -86.04% ABP -98.23% Spread: +101.36 pp (RADX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RADX TTM Op. Margin: -411.6% ABP TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RADX vs ABP. Trailing 12-month operating profitability (RADX -411.6% vs ABP 0.0%) and valuation multiples (RADX N/M vs ABP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RADX (2) vs ABP (3)
Institutional Metric RADX ABP Criterion Row Winner
Market Capitalization Scale $10.6M $2.2M Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -36.9% -100.0% Higher Growth RADX
Operating Margin (TTM) Profitability -411.6% 0.0% Higher Margin ABP
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -174.7% 0.0% Higher ROE ABP
52-Week Range Position Momentum 0% ($1โ€“$16) 0% ($1โ€“$32) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 0.52ฮฒ ยท 109% Vol 2.33ฮฒ ยท 258% Vol Lower Realized Risk RADX
Unified Institutional Score Composite Signal 41.1 / 100 (SELL) 44.4 / 100 (HOLD) Higher Composite ABP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RADX vs ABP Buy Guide
RADX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RADX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RADX nor ABP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.